D-0502

· InventisBio Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for D-0502, covering 2026-01-13 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer [Phase 3]